Reducing delirium and cognitive dysfunction after off-pump coronary bypass: A randomized trial

Krzysztof Szwed1, Wojciech Pawliszak2, Magdalena Szwed1

  • 1Department of Clinical Neuropsychology, Collegium Medium, Nicolaus Copernicus University, Bydgoszcz, Poland.

Abstract

Insights

Anaortic off-pump coronary artery bypass (OPCAB) significantly reduces postoperative delirium and cognitive dysfunction compared to conventional OPCAB. Carbon dioxide flooding showed no significant benefit in this study.

Area of Science:

  • Cardiovascular Surgery
  • Neuroscience
  • Anesthesiology

Background:

  • Neuropsychiatric complications are common after coronary revascularization surgery.
  • Existing methods like off-pump coronary artery bypass (OPCAB) have not fully addressed these complications.
  • This study investigates novel OPCAB modifications to mitigate these adverse effects.

Purpose of the Study:

  • To evaluate the efficacy of two modified OPCAB techniques in reducing neuropsychiatric complications.
  • To compare anaortic OPCAB (ANA) and OPCAB with CO2 surgical field flooding (CO2FF) against conventional OPCAB.

Main Methods:

  • A single-center, randomized controlled trial involving 192 patients undergoing elective OPCAB.
  • Patients were randomized into three groups: conventional OPCAB, ANA with total arterial revascularization, and OPCAB with CO2FF.
  • Primary outcomes were the incidence of postoperative delirium (PD) and early postoperative cognitive dysfunction (ePOCD).

Main Results:

  • The incidence of PD was significantly lower in the ANA group (12.5%) compared to conventional OPCAB (35.9%).
  • The incidence of ePOCD was also significantly lower in the ANA group (9.5%) versus conventional OPCAB (34.4%).
  • CO2FF did not show a significant reduction in PD or ePOCD compared to conventional OPCAB.

Conclusions:

  • Anaortic OPCAB (ANA) significantly decreases the incidence of postoperative delirium and early postoperative cognitive dysfunction.
  • CO2 surgical field flooding (CO2FF) did not demonstrate a significant benefit in reducing these neuropsychiatric sequelae.
  • ANA may improve clinical outcomes by potentially reducing embolic load to the brain during coronary revascularization.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
179
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
191
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
199
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
554